Spinal Cord Injury Product Makes Progress As Asterias Picks Up Where Geron Left Off
This article was originally published in The Pink Sheet Daily
Executive Summary
New endpoint guidelines – and matching grant funding from the California Institute for Regenerative Medicine – enhance possibility of demonstrating functional improvement in the Phase I/IIa trial of the stem-cell therapeutic.